ConductScience.org, home

Paper8610340

Short course single agent therapy with an LFA-3-IgG1 fusion protein prolongs primate cardiac allograft survival.

Kaplon RJ and 10 others. Transplantation, 1996. Cited by 51 papers, by iCite.

Cite this record

ConductScience Library. Short course single agent therapy with an LFA-3-IgG1 fusion protein prolongs primate cardiac allograft survival. Papers, record 8610340. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8610340

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Short course single agent therapy with an LFA-3-IgG1 fusion protein prolongs primate cardiac allograft survival.
PubMed
Journal
Transplantation
PubMed
Year
1996
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
1.19
iCite
Revised in PubMed
2019-07-13
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kaplon RJR J
2Hochman PSP S
3Michler RER E
4Kwiatkowski PAP A
5Edwards NMN M
6Berger CLC L
7Xu HH
8Meier WW
9Wallner BPB P
10Chisholm PP
11Marboe CCC C

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CD58 AntigensMajor topic
Heart TransplantationMajor topic
Immunoglobulin GMajor topic
Animals
Antibodies, Monoclonal
CD2 Antigens
Graft Rejection
Graft Survival
Humans
Immunotherapy
In Vitro Techniques
Lymphocyte Culture Test, Mixed
Papio
Recombinant Fusion Proteins
Time Factors
Transplantation, Heterotopic
Transplantation, Homologous

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01163799A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant RecipientsBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
30455699In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells.Front Immunol2018https://conductscience.org/library/papers/30455699PubMed
27110598Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir?Immunotherapy (Los Angel)2015https://conductscience.org/library/papers/27110598PubMed
26095669Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases.Biol Blood Marrow Transplant2015https://conductscience.org/library/papers/26095669PubMed
24003248Primate models in organ transplantation.Cold Spring Harb Perspect Med2013https://conductscience.org/library/papers/24003248PubMed
23818516Lymphodepletional strategies in transplantation.Cold Spring Harb Perspect Med2013https://conductscience.org/library/papers/23818516PubMed
20964456Co-stimulation blockade as a new strategy in kidney transplantation: benefits and limits.Drugs2010https://conductscience.org/library/papers/20964456PubMed
20125095Advances in immunosuppression for renal transplantation.Nat Rev Nephrol2010https://conductscience.org/library/papers/20125095PubMed
16247429Rapid response to alefacept given to patients with steroid resistant or steroid dependent acute graft-versus-host disease: a preliminary report.Bone Marrow Transplant2005https://conductscience.org/library/papers/16247429PubMed
16190751Structure-activity studies of peptides from the "hot-spot" region of human CD2 protein: development of peptides for immunomodulation.J Med Chem2005https://conductscience.org/library/papers/16190751PubMed
10490759Gene therapy in transplantation.Gene Ther1999https://conductscience.org/library/papers/10490759PubMed
10357807Functional glycan-free adhesion domain of human cell surface receptor CD58: design, production and NMR studies.EMBO J1999https://conductscience.org/library/papers/10357807PubMed
9339960Prevention of transplant rejection: current treatment guidelines and future developments.Drugs1997https://conductscience.org/library/papers/9339960PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD2914PubTator's text mininghttps://conductscience.org/library/genes/914NCBI Gene
CD58965PubTator's text mininghttps://conductscience.org/library/genes/965NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8610340

GET https://conductscience.org/api/papers/v1/8610340/authors